Molecular conjugates for use in treatment of cancer

Details for Australian Patent Application No. 2002254400 (hide)

Owner Napro Biotherapeutics, Inc.

Inventors Chander, Madhavi C.; Ainsworth, Sterling K.; Siahaan, Teruna J.; McChesney, James D.; Xu, Christine R.

Agent Patent Attorney Services

Pub. Number AU-B-2002254400

PCT Pub. Number WO2002/076448

Priority 60/278,243 23.03.01 US

Filing date 25 March 2002

Wipo publication date 8 October 2002

Acceptance publication date 9 August 2007

International Classifications

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4375 (2006.01)

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/704 (2006.01)

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07D 305/14 (2006.01) Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms

C07D 311/82 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 491/22 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07H 15/252 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

C07K 14/79 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002254400

6 October 2005 Amendment Made

  The nature of the amendment is: Add co-inventor Ainsworth, Sterling K.

9 August 2007 Application Accepted

  Published as AU-B-2002254400

6 December 2007 Standard Patent Sealed

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002254401-A TRANSPINNOR-BASED SWITCH AND APPLICATIONS

2002254399-NOVEL TYROSINE KINASE INHIBITORS